A detailed history of Pathstone Holdings, LLC transactions in Personalis, Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 14,905 shares of PSNL stock, worth $90,771. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,905
Previous 35,528 58.05%
Holding current value
$90,771
Previous $41,000 95.12%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$1.19 - $6.34 $24,541 - $130,749
-20,623 Reduced 58.05%
14,905 $80,000
Q2 2024

Aug 14, 2024

SELL
$1.17 - $1.65 $567 - $800
-485 Reduced 1.35%
35,528 $41,000
Q1 2024

May 13, 2024

SELL
$1.15 - $2.19 $440 - $838
-383 Reduced 1.05%
36,013 $53,000
Q4 2023

Feb 14, 2024

BUY
$0.93 - $2.35 $33,848 - $85,530
36,396 New
36,396 $76,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $280M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.